Digitale Bibliotheek
Sluiten Bladeren door artikelen uit een tijdschrift
     Tijdschrift beschrijving
       Alle jaargangen van het bijbehorende tijdschrift
         Alle afleveringen van het bijbehorende jaargang
                                       Alle artikelen van de bijbehorende aflevering
 
                             30 gevonden resultaten
nr titel auteur tijdschrift jaar jaarg. afl. pagina('s) type
1 Clinical Trial Patient-reported Outcomes Data: Going Beyond the Label in Oncology Hao, Yanni
2016
38 4 p. 811-820
10 p.
artikel
2 Comments on Watson, the Microbiome of Children, and Patient-reported Outcomes Shader, Richard I.
2016
38 4 p. 683-685
3 p.
artikel
3 Cost-effectiveness of First-line Chronic Lymphocytic Leukemia Treatments When Full-dose Fludarabine Is Unsuitable Soini, Erkki
2016
38 4 p. 889-904.e14
9.03999999999991E16 p.
artikel
4 Development of the Neonatal Intestinal Microbiome and Its Association With Necrotizing Enterocolitis Elgin, Timothy G.
2016
38 4 p. 706-715
10 p.
artikel
5 Drug Therapy for Rate and Rhythm Control in Nonvalvular Atrial Fibrillation: A Cross-sectional Study With Electronic Health Records in a Primary Care Cohort Giner-Soriano, Maria
2016
38 4 p. 863-873
11 p.
artikel
6 Dual Antiplatelet Therapy Duration: A Review of Current Available Evidence Mastoris, Ioannis
2016
38 4 p. 961-973
13 p.
artikel
7 Editorial Board 2016
38 4 p. A2-
1 p.
artikel
8 Effectiveness of Everolimus Versus Endocrine Monotherapy or Chemotherapy Among HR+/HER2− mBC Patients With Multiple Metastatic Sites Li, Nanxin
2016
38 4 p. 905-917
13 p.
artikel
9 Effects of Modafinil and Armodafinil in Patients With Obstructive Sleep Apnea: A Meta-analysis of Randomized Controlled Trials Kuan, Yi-Chun
2016
38 4 p. 874-888
15 p.
artikel
10 Efficacy and Safety of the SGLT2 Inhibitor Luseogliflozin in Japanese Patients With Type 2 Diabetes Mellitus Stratified According to Baseline Body Mass Index: Pooled Analysis of Data From 52-Week Phase III Trials Sakai, Soichi
2016
38 4 p. 843-862.e9
8.61999999158E11 p.
artikel
11 From Bottles to Diapers: How Manipulating and Exploring the Microbiome Is Defining Newborn Care Maron, Jill L.
2016
38 4 p. 704-705
2 p.
artikel
12 IBM Watson: How Cognitive Computing Can Be Applied to Big Data Challenges in Life Sciences Research Chen, Ying
2016
38 4 p. 688-701
14 p.
artikel
13 Increasing Incidence of Thyroid Nodules and Thyroid Cancer: Does Increased Detection of a Subclinical Reservoir Justify the Associated Anxiety and Treatment? Ukrainski, Melinda B.
2016
38 4 p. 976-985
10 p.
artikel
14 Methods for Implementing and Reporting Patient-reported Outcome (PRO) Measures of Symptomatic Adverse Events in Cancer Clinical Trials Basch, Ethan
2016
38 4 p. 821-830
10 p.
artikel
15 Neonatal Gastrointestinal and Respiratory Microbiome in Cystic Fibrosis: Potential Interactions and Implications for Systemic Health Madan, Juliette C.
2016
38 4 p. 740-746
7 p.
artikel
16 New Formulations of Old Analgesics and Repurposing of Old Drugs as “New” Analgesics Ruan, Xiulu
2016
38 4 p. 988-989
2 p.
artikel
17 Opportunity Cost and Policy: A Utilization Review of Self-monitoring of Blood Glucose in Manitoba, Canada Serwylo, Olena
2016
38 4 p. 929-935
7 p.
artikel
18 Patient-reported Symptom Experiences in Patients With Carcinoid Syndrome After Participation in a Study of Telotristat Etiprate: A Qualitative Interview Approach Gelhorn, Heather L.
2016
38 4 p. 759-768
10 p.
artikel
19 Patient-reported Symptoms of Tenosynovial Giant Cell Tumors Gelhorn, Heather L.
2016
38 4 p. 778-793
16 p.
artikel
20 Pharmacokinetics, Efficacy, and Safety of Nonacog Alfa in Previously Treated Patients with Moderately Severe to Severe Hemophilia B Korth-Bradley, Joan M.
2016
38 4 p. 936-944
9 p.
artikel
21 Prevention of Necrotizing Enterocolitis Through Manipulation of the Intestinal Microbiota of the Premature Infant Vongbhavit, Kannikar
2016
38 4 p. 716-732
17 p.
artikel
22 Qualitative Development and Content Validity of the Non–small Cell Lung Cancer Symptom Assessment Questionnaire (NSCLC-SAQ), A Patient-reported Outcome Instrument McCarrier, Kelly P.
2016
38 4 p. 794-810
17 p.
artikel
23 Reducing Adverse Effects During Drug Development: The Example of Lesogaberan and Paresthesia Rydholm, Hans
2016
38 4 p. 946-960
15 p.
artikel
24 Safety of the Up-titration of Nifedipine GITS and Valsartan or Low-dose Combination in Uncontrolled Hypertension: the FOCUS Study Park, Jeong Bae
2016
38 4 p. 832-842
11 p.
artikel
25 Table of Contents 2016
38 4 p. A4-A6
nvt p.
artikel
26 The Developing Microbiome of the Preterm Infant DiBartolomeo, Mara E.
2016
38 4 p. 733-739
7 p.
artikel
27 The Hypoxia-inducible Factor Prolyl-Hydroxylase Inhibitor Roxadustat (FG-4592) and Warfarin in Healthy Volunteers: A Pharmacokinetic and Pharmacodynamic Drug–Drug Interaction Study Groenendaal-van de Meent, Dorien
2016
38 4 p. 918-928
11 p.
artikel
28 The Microbiome in Necrotizing Enterocolitis: A Case Report in Twins and Minireview Hourigan, Suchitra K.
2016
38 4 p. 747-753
7 p.
artikel
29 The Use of Patient-reported Outcomes in Demonstrating Safety and Efficacy in Oncology Coon, Cheryl D.
2016
38 4 p. 756-758
3 p.
artikel
30 Using Patient-reported Outcomes to Compare Relative Burden of Cancer: EQ-5D and Functional Assessment of Cancer Therapy-General in Eleven Types of Cancer Pickard, A. Simon
2016
38 4 p. 769-777
9 p.
artikel
                             30 gevonden resultaten
 
 Koninklijke Bibliotheek - Nationale Bibliotheek van Nederland